Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
National Pension Service Has $334.14 Million Stock Position in Amgen Inc. $AMGN
03:23am, Saturday, 31'st Jan 2026
National Pension Service boosted its holdings in Amgen Inc. (NASDAQ: AMGN) by 3.3% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The instit
Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends
01:09pm, Friday, 30'th Jan 2026
Kyowa Kirin Co., Ltd. and Amgen Inc. (NASDAQ: AMGN) terminated on Friday the current rocatinlimab development and commercialization collaboration.
Alpha Cubed Investments LLC Reduces Holdings in Amgen Inc. $AMGN
03:08am, Friday, 30'th Jan 2026
Alpha Cubed Investments LLC cut its position in Amgen Inc. (NASDAQ: AMGN) by 19.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fi
Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Thursday, 29'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Countdown to Amgen (AMGN) Q4 Earnings: Wall Street Forecasts for Key Metrics
10:16am, Thursday, 29'th Jan 2026
Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Ballentine Partners LLC Trims Holdings in Amgen Inc. $AMGN
04:26am, Thursday, 29'th Jan 2026
Ballentine Partners LLC decreased its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 17.1% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned
Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.
08:30pm, Wednesday, 28'th Jan 2026
Eli Lilly's stock trades at more than 30 times forward earnings, which is a steep price to pay right now. Amgen is a much cheaper option by comparison.
AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
04:01pm, Wednesday, 28'th Jan 2026
THOUSAND OAKS, Calif., Jan. 28, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2025 financial results on Tuesday, February 3, 2026, afte
Amgen Set to Report Q4 Earnings: What Investors Should Know
12:27pm, Wednesday, 28'th Jan 2026
AMGN stock is in focus ahead of Q4 earnings, with biosimilar pressure and newer drug growth shaping expectations for the quarter.
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
11:01am, Tuesday, 27'th Jan 2026
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen (AMGN) to Release Quarterly Earnings on Tuesday
03:10am, Tuesday, 27'th Jan 2026
Amgen (NASDAQ: AMGN - Get Free Report) is projected to release its Q4 2025 results after the market closes on Tuesday, February 3rd. Analysts expect Amgen to post earnings of $4.74 per share and reven
Amgen (AMGN) Laps the Stock Market: Here's Why
06:50pm, Monday, 26'th Jan 2026
In the most recent trading session, Amgen (AMGN) closed at $349.69, indicating a +1.43% shift from the previous trading day.
Here's Why Amgen (AMGN) is a Strong Momentum Stock
10:51am, Monday, 26'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cullen Frost Bankers Inc. Decreases Position in Amgen Inc. $AMGN
05:28am, Sunday, 25'th Jan 2026
Cullen Frost Bankers Inc. trimmed its holdings in Amgen Inc. (NASDAQ: AMGN) by 9.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The insti
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:00am, Friday, 23'rd Jan 2026
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
